FDA Drug Application (202074) for OLANZAPINE AND FLUOXETINE HYDROCHLORIDE by TEVA PHARMS

Back to FDA Applications sponsored by TEVA PHARMS

Application Number202074
Product Number001
FormCAPSULE;ORAL
DosageEQ 25MG BASE;EQ 3MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Active IngredientFLUOXETINE HYDROCHLORIDE; OLANZAPINE



Back to FDA Applications sponsored by TEVA PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.